Trade AXGN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Axogen, Inc. (AXGN) is trading at US$44.23, down 2.33% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$2.71B. Over the past 52 weeks, AXGN has traded between US$15.27 and US$52.91. On Syfe you can trade AXGN with $0 commission and add it to your watchlist.
| Previous close | US$45.29 |
|---|---|
| Market cap | US$2.71B |
| P/E ratio | 71.61 |
| 52-week range | US$15.27 – US$52.91 |
| Volume | 1.12M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Axogen, Inc.
Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Avive Soft Tissue Membrane, AcroVal Neurosensory and Motor Testing System, and AxoTouch Two-Point Discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Year: 1986
Axogen, Inc. (AXGN) stock is trading at US$44.23, -2.33% from the previous close of US$45.29.
The market cap for Axogen, Inc. (AXGN) stock is approximately US$2.71B.
The price-to-earnings ratio for Axogen, Inc. (AXGN) is 71.61, based on the latest reported earnings.
The 52-week high for Axogen, Inc. (AXGN) stock is US$52.91.
The 52-week low for Axogen, Inc. (AXGN) stock is US$15.27.
Axogen, Inc. (AXGN) does not currently pay a dividend.
Stay on top of AXGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
